Motevalli, Mohammad Hossein, Saeed Taheri, Farzad Peiravian, and Nazila Yousefi. “Cost-Effectiveness of Sorafenib for Metastatic Renal Cell Carcinoma: A Systematic Review”. International Pharmacy Acta 2, no. 1 (December 20, 2019): 2e10:1–6. Accessed May 16, 2025. https://journals.sbmu.ac.ir/acta/article/view/24856.